Alton Sutnick  Alton Ivan Sutnick (born July 6, 1928 in Trenton, New Jersey) is an American medical researcher, educator and administrator. He is the author of over 200 scholarly publications. In 1950, Alton Sutnick received his bachelor's degree in chemistry from the University of Pennsylvania and in 1954, he received his medical degree from the University of Pennsylvania School of Medicine. In 1961 Dr. Sutnick established a laboratory for the study of pulmonary surfactant at Temple University School of Medicine. He was the first medical researcher to apply pulmonary surfactant physiological observations to adult human lung disease, including pneumonia, lung cancer and pulmonary embolism, which are all associated with atelectasis. Between 1958 and 1965, Sutnick conducted research on new drug and surgical treatments for hypertension while he was a fellow at the University of Pennsylvania School of Medicine, chief of medicine of the U.S. Army Hospital in Paris, and a faculty member at the Temple University School of Medicine. As chief of medicine at the army hospital, Sutnick observed and evaluated the first human blood marrow transplants, administered by Georges Mathé to six Yugoslav physicists who had been inadvertently exposed to lethal doses of radiation in 1959. Sutnick later served as a member of the National Heart, Lung and Blood Institute's National High Blood Pressure Education Working Group. In 1965, Sutnick joined Dr. Baruch Blumberg at The Institute for Cancer Research. Blumberg had discovered what appeared to be a persistent trait in the blood of some populations which he called "Australia antigen". Sutnick found that it was acquired and associated with inflammatory disease of the liver, drawing “the first formal connection between the mysterious antigen and hepatitis” recognizing that the antigen was likely part of a hepatitis virus. Subsequent studies confirmed that it was indeed Hepatitis B virus, so Sutnick’s observation led directly to the prevention of transfusion hepatitis, the hepatitis B vaccine, and the award of the Nobel Prize to Dr. Blumberg. In 1972, Sutnick was one of the first to describe an entity that became known as hepatitis C. The recognition of Hepatitis B antigen occurred in patients with Down’s Syndrome, so they became a related subject of investigation, particularly as a model for leukemia susceptibility. Sutnick was the first to recognize the relationship of iron stores to cancer susceptibility, and reduced life expectancy. This happened at the time when the American Oncologic Hospital became part of the Fox Chase Cancer Center. Sutnick, already Associate Director of the Institute, was appointed Director of Clinical Development for the hospital, and brought on the first full-time academic clinicians.